IPOs

Beta Bionics targets $695 mln valuation in upsized US IPO
Medtech Dive
Tue, 01/28/25 - 10:42 am
Medtech
Beta Bionics
IPOs
insulin pumps
diabetes
Maze rolls out map to $131M IPO, as phase 2 kidney disease trial readies for dosing
Fierce Biotech
Tue, 01/28/25 - 10:41 am
Maze Therapeutics
IPOs
kidney disease
clinical trials
Metsera eyes $289M IPO to fund phase 3 weight loss trial
Fierce Biotech
Mon, 01/27/25 - 11:32 am
Metsera
obesity
IPOs
GLP-1 agonists
MET-097i
Vision loss biotech Aurion Biotech files for a $100 million IPO
Renaissance Capital
Mon, 01/27/25 - 11:29 am
Aurion Biotech
cell therapy
IPOs
vision loss
Ascentage raises $126m in first biotech IPO of 2025
Pharmaphorum
Mon, 01/27/25 - 11:15 am
Ascentage Pharma
IPOs
cancer
‘A really rational IPO environment’: What does it takes for a biotech to go public now?
Fierce Biotech
Fri, 01/24/25 - 11:44 am
biotech
IPOs
Septerna
Sofinnova
Rapport Therapeutics
Obesity biotech Aardvark eyes IPO as Ascentage makes $126M Nasdaq debut
Fierce Biotech
Fri, 01/24/25 - 11:21 am
IPOs
Aardvark Therapeutics
Ascentage Pharma
Here’s Why Beta Bionics Filing for an IPO Is a Big Deal
Medical Devices and Diagnostics Industry
Thu, 01/23/25 - 11:09 pm
Medtech
Beta Bionics
IPOs
iLet Bionic Pancreas
GSK, Merck and Pfizer in Ab&B’s sights as Chinese vaccine biotech files for IPO
Fierce Biotech
Thu, 01/23/25 - 11:40 am
Ab&B Bio-Tech
GSK
Merck
Pfizer
China
vaccines
IPOs
BMS, Takeda's Chinese partners file for IPOs, sending Ascentage, Biokin and Bao bundling toward listings
Fierce Biotech
Wed, 01/22/25 - 07:28 pm
China
Takeda
Bristol Myers Squibb
IPOs
Ascentage Pharma
Sichuan Biokin Pharmaceutical
Shanghai Bao
Sionna, Odyssey join queue of biotechs testing investors’ IPO interest
BioPharma Dive
Tue, 01/21/25 - 11:16 am
IPOs
Sionna Therapeutics
cystic fibrosis
Odyssey Therapeutics
ulcerative colitis
5 questions facing emerging biotech in 2025
BioPharma Dive
Tue, 01/14/25 - 11:22 am
biotech
funding
China
IPOs
cell therapy
gene therapy
M&A
Maze Therapeutics looks for IPO lodestar to guide kidney disease assets through clinical trials
Fierce Biotech
Tue, 01/7/25 - 07:04 pm
Maze Therapeutics
IPOs
kidney disease
Health In Tech IPO Fuels AI-Driven Health Coverage for Small Businesses
Xtalks
Sun, 01/5/25 - 09:33 pm
Health In Tech
IPOs
artificial intelligence
insurance
Analysts predict M&A, IPO uptick in 2025 but don't expect 'floodgates to suddenly open'
Fierce Biotech
Fri, 01/3/25 - 11:17 am
IPOs
M&A
Anteris IPO Helps Bring Minimally Invasive Heart Valve Innovations
Xtalks
Fri, 01/3/25 - 10:52 am
Medtech
Anteris
IPOs
heart valve
Medline sets stage for blockbuster US IPO with confidential filing
MSN/Reuters
Thu, 12/19/24 - 10:10 am
Medline
IPOs
medical supplies
Medtech
Invizyne’s IPO Aims to Bring Sustainable Biomanufacturing
Xtalks
Fri, 12/6/24 - 09:36 am
IPOs
Invizyne
Biomanufacturing
What can we learn from 2024’s biotech IPOs?
Fierce Biotech
Fri, 12/6/24 - 09:25 am
biotech
IPOs
Jupiter Neurosciences Makes Way in CNS Treatments with $11M IPO
Xtalks
Wed, 12/4/24 - 11:09 pm
Jupiter Neurosciences
CNS
IPOs

Pages